Abstract
We describe a generic plasmid purification process for producing DNA for larger-scale transient transfection. Data on plasmid quality with regard to residual protein, endotoxin content and presence of different plasmid forms is given. The effects of contaminants and plasmid forms on expression levels of TNFRp55 and SEAP are discussed. Transient transfection of serum-free suspension grown mammalian cells represents a suitable approach to provide research quantities of proteins (50–100 mg) within1–2 weeks.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berger J, Hauber J, Hauber R, Gelger R & Cullen BR (1988) Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66: 1–10.
Birnboim HC (1983) A rapid alkaline extraction method for the isolation of plasmid DNA. Methods Enzymol 100: 243–255.
Boussif O, Lezoualc' HF, Zanta MA, Mergny MD, Scherman D, Demeneix B, & Behr J-P (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 92: 7297–7301.
Chandra G, Patel P, Kost TA & Gray JG (1992) Large-scale purification of plasmid DNA by fast protein liquid chromatography using a Hi-Load Q Sepharose column. Analyt Biochem 203: 169–172.
Colpan M & Riesner D (1984) High-performance liquid chromatography of high-molecular-weight nucleic acids on the macroporous ion exchanger. Nucleogen J Chromatogr 296: 339–353.
Ferreira GNM, Monterio GA, Prazeres DMF & Cabral JMS (2000). Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotechnol 18: 380–388.
Godfried MH, van der Poll T, Weverling GJ, Mulder JW, Jansen J, van Deventer SJH & Sauerwein HP (1994) Soluble receptors for tumor necrosis factor as predictors of progression to Aids in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 169: 739–745.
Hines RN, O'Conner KC, Vella G & Warren W (1992) Largescale purification of plasmid DNA by anion-exchange highperformance liquid chromatography. BioTechniques 12: 430–434.
Horn NA, Meek JA, Budahazi G & Marquet M (1995) Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials. Hum Gen Ther 6: 565–573.
Kahn DW, Butler MD, Cohen DL, Gordon M, Kahn JW & Winkler ME (2000) Purification of plasmid DNA by tangential flow filtration. Biotechnol Bioeng 69: 101–106.
Lahijani R, Hulley G, Soriano G, Horn NA & Marquet M (1996) High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum Gene Ther 7: 1971–1980.
Loetscher H, Pan YCE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H & Lesslauer W(1990) Molecular cloning and expression of the human 55kd tumor necrosis factor receptor. Cell 61: 351–359.
McClung JK & Gonzales RA (1989) Purification of plasmid DNA by fast protein liquid chromatography on Superose 6 preparative grade. Anal Biochem 177: 378–382.
Merion M & Warren W (1989) Purification of supercoiled plasmids from crude cell lysates using high performance anion exchange chromatography. BioTechniques 7: 60–67.
Mitzner S, Schneidewind J, Falkenhagen D, Loth F & Klinkmann H (1993) Extracorporeal endotoxin removal by immobilized polyethylenimine. Artif Organs 17: 775–781.
Montbriand PM & Malone RW (1996) Improved method for the removal of endotoxin from DNA. J Biotechnol 44: 43–46.
Prazeres DMF, Ferreira GNM, Monteiro GA, Cooney CL & Cabral JMS (1999) Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol 17: 169–174.
Raymond GJ, Bryant III PK, Nelson A & Johnson JD (1988) Large-scale isolation of covalently closed circular DNA using gel filtration chromatography. Anal Biochem 173: 125–133.
Sayers JR, Evans D & Thomson JB (1996) Identification and eradication of a denatured DNA isolated during alkaline lysis-based plasmid purification procedures. Anal Biochem 241: 186–189.
Schlaeger E-J & Christensen K (1999) Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology 30: 71–83.
Schlaeger E-J, Christensen K & Kitas EA (1999) Scale-up of transient gene expression in mammalian cells grown in serum-free suspension culture. Presentation at the 4th Gene Delivery & Cellular Protein Expression Conference, Lake Tahoe, CA.
Schorr J, Moritz P, Weber M & Schleef M (1997) Nucleic acids for therapeutic applications: Pharmaceutical quality with industrial scale production, Poster at: Gene Therapy Meeting, Cold Spring Harbor, NY, USA.
Schumpp B & Schlaeger E-J (1990) Optimization of culture conditions for high cell density proliferation of HL60 human promyelocytic leukemia cells. J Cell Science 97: 639–647.
Wils P, Escriou V, Warnery A, Lacroix F, Lagneaux D, Ollivier M, Cruzet J, Mayaux J-F & Scherman D (1997) Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography. Gene Ther 4: 323–330.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmid, G., Schlaeger, EJ. & Wipf, B. Non-GMP plasmid production for transient transfection in bioreactors. Cytotechnology 35, 157–164 (2001). https://doi.org/10.1023/A:1013148203049
Issue Date:
DOI: https://doi.org/10.1023/A:1013148203049